Hikal Limited Reports Consolidated and Standalone Earnings Results for Fourth Quarter and Full Year Ended March 31, 2016
May 06, 2016 at 06:50 am EDT
Share
Hikal Limited reported consolidated and standalone earnings results for fourth quarter and full year ended March 31, 2016. For the quarter, the company reported net sales/income from operations of INR 2,897.9 million, profit from operations before other income and finance costs and exceptional items of INR 422.0 million, profit from ordinary activities before tax of INR 292.6 million, net profit of INR 222.4 million or INR 2.71 per basic and diluted share, compared to the net sales/income from operations of INR 2,135.3 million, profit from operations before other income and finance costs and exceptional items of INR 266.1 million, profit from ordinary activities before tax of INR 177.5 million, net profit of INR 101.9 million or INR 1.24 per basic and diluted share, for the same quarter a year ago.
For the year to date, the company reported net sales/income from operations of INR 9,256.5 million, profit from operations before other income and finance costs and exceptional items of INR 1,136.5 million, profit from ordinary activities before tax of INR 533.1 million, net profit of INR 413.1 million or INR 5.03 per basic and diluted share, compared to the net sales/income from operations of INR 8,718.6 million, profit from operations before other income and finance costs and exceptional items of INR 1,183.4 million, profit from ordinary activities before tax of INR 598.7 million, net profit of INR 405.2 million or INR 4.93 per basic and diluted share, for the same period a year ago.
For the quarter, the company consolidated reported net sales/income from operations of INR 9,256.3 million, profit from operations before other income and finance costs and exceptional items of INR 1,135.6 million, profit from ordinary activities before tax of INR 531.9 million, net profit of INR 411.9 million or INR 5.01 per basic and diluted share, compared to the net sales/income from operations of INR 8,718.6 million, profit from operations before other income and finance costs and exceptional items of INR 1,182.3 million, profit from ordinary activities before tax of INR 597.6 million, net profit of INR 404.1 million or INR 4.92 per basic and diluted share, for the same quarter a year ago.
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.
HIKAL LIMITED 
